CZ20012973A3 - Agonisté dopamin D1 receptoru - Google Patents
Agonisté dopamin D1 receptoru Download PDFInfo
- Publication number
- CZ20012973A3 CZ20012973A3 CZ20012973A CZ20012973A CZ20012973A3 CZ 20012973 A3 CZ20012973 A3 CZ 20012973A3 CZ 20012973 A CZ20012973 A CZ 20012973A CZ 20012973 A CZ20012973 A CZ 20012973A CZ 20012973 A3 CZ20012973 A3 CZ 20012973A3
- Authority
- CZ
- Czechia
- Prior art keywords
- hydrogen
- chloro
- tetrahydro
- mmol
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9903671.7A GB9903671D0 (en) | 1999-02-17 | 1999-02-17 | Dopamine D-1 receptor agonist compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ20012973A3 true CZ20012973A3 (cs) | 2002-01-16 |
Family
ID=10847990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ20012973A CZ20012973A3 (cs) | 1999-02-17 | 2000-02-17 | Agonisté dopamin D1 receptoru |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1157009A1 (hu) |
JP (1) | JP2002537288A (hu) |
KR (1) | KR20010108228A (hu) |
CN (1) | CN1142916C (hu) |
AU (1) | AU767332B2 (hu) |
BR (1) | BR0008329A (hu) |
CA (1) | CA2363695A1 (hu) |
CZ (1) | CZ20012973A3 (hu) |
EA (1) | EA004745B1 (hu) |
GB (1) | GB9903671D0 (hu) |
HU (1) | HUP0200057A3 (hu) |
IL (1) | IL144810A0 (hu) |
MX (1) | MXPA01008294A (hu) |
NO (1) | NO20013978L (hu) |
PL (1) | PL349838A1 (hu) |
WO (1) | WO2000049000A1 (hu) |
ZA (1) | ZA200106478B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
CN101495184A (zh) * | 2005-07-15 | 2009-07-29 | Amr科技公司 | 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用 |
US20090022739A1 (en) * | 2005-08-03 | 2009-01-22 | Mia Levite | MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHA |
CN101684096A (zh) * | 2008-09-23 | 2010-03-31 | 中国科学院上海药物研究所 | 一类新型苯并氮杂卓类化合物及其制备方法和用途 |
CN102276531A (zh) * | 2011-05-30 | 2011-12-14 | 扬子江药业集团广州海瑞药业有限公司 | 一种甲磺酸非诺多泮的制备方法 |
PT3013813T (pt) | 2013-06-27 | 2019-06-14 | Pfizer | Compostos heteroaromáticos e a sua utilização como ligandos de d1 de dopamina |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1561305A (en) * | 1975-07-02 | 1980-02-20 | Smithkline Corp | Benzazepine derivatives and pharmeceutical compositions containing them |
US4111957A (en) * | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
US4265889A (en) * | 1978-05-05 | 1981-05-05 | Smithkline Corporation | 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
US4861771A (en) * | 1989-01-27 | 1989-08-29 | Smithkline Beckman Corporation | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs |
-
1999
- 1999-02-17 GB GBGB9903671.7A patent/GB9903671D0/en not_active Ceased
-
2000
- 2000-02-17 CN CNB00803947XA patent/CN1142916C/zh not_active Expired - Fee Related
- 2000-02-17 JP JP2000599740A patent/JP2002537288A/ja active Pending
- 2000-02-17 CZ CZ20012973A patent/CZ20012973A3/cs unknown
- 2000-02-17 AU AU25632/00A patent/AU767332B2/en not_active Ceased
- 2000-02-17 EP EP00903881A patent/EP1157009A1/en not_active Withdrawn
- 2000-02-17 MX MXPA01008294A patent/MXPA01008294A/es unknown
- 2000-02-17 BR BR0008329-1A patent/BR0008329A/pt not_active IP Right Cessation
- 2000-02-17 WO PCT/GB2000/000570 patent/WO2000049000A1/en not_active Application Discontinuation
- 2000-02-17 CA CA002363695A patent/CA2363695A1/en not_active Abandoned
- 2000-02-17 HU HU0200057A patent/HUP0200057A3/hu unknown
- 2000-02-17 IL IL14481000A patent/IL144810A0/xx unknown
- 2000-02-17 KR KR1020017010418A patent/KR20010108228A/ko not_active Application Discontinuation
- 2000-02-17 EA EA200100783A patent/EA004745B1/ru not_active IP Right Cessation
- 2000-02-17 PL PL00349838A patent/PL349838A1/xx not_active Application Discontinuation
-
2001
- 2001-08-07 ZA ZA200106478A patent/ZA200106478B/en unknown
- 2001-08-15 NO NO20013978A patent/NO20013978L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL144810A0 (en) | 2002-06-30 |
HUP0200057A2 (en) | 2002-08-28 |
KR20010108228A (ko) | 2001-12-07 |
NO20013978D0 (no) | 2001-08-15 |
CN1142916C (zh) | 2004-03-24 |
AU2563200A (en) | 2000-09-04 |
GB9903671D0 (en) | 1999-04-14 |
WO2000049000A1 (en) | 2000-08-24 |
CN1341102A (zh) | 2002-03-20 |
JP2002537288A (ja) | 2002-11-05 |
PL349838A1 (en) | 2002-09-23 |
HUP0200057A3 (en) | 2004-03-29 |
EA200100783A1 (ru) | 2002-02-28 |
EA004745B1 (ru) | 2004-08-26 |
AU767332B2 (en) | 2003-11-06 |
CA2363695A1 (en) | 2000-08-24 |
MXPA01008294A (es) | 2002-07-02 |
EP1157009A1 (en) | 2001-11-28 |
ZA200106478B (en) | 2002-02-07 |
BR0008329A (pt) | 2002-01-29 |
NO20013978L (no) | 2001-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK133198A3 (en) | Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing them | |
EP1337528B1 (en) | Benzothiophene derivative compounds, process of preparation and use thereof | |
IE62704B1 (en) | Substituted aminomethyltetralins and their heterocyclic analogues | |
SK284028B6 (sk) | Tetracyklický derivát tetrahydrofuránu substituovaný halogénom, spôsob jeho prípravy a použitie a farmaceutický prostriedok na jeho báze | |
WO2013026455A1 (en) | Permanently positively charged antidepressants | |
KR101386387B1 (ko) | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 결정성 염기 | |
JP2669579B2 (ja) | オキサゾリドン誘導体 | |
US5084454A (en) | 2-(piperidinylmethyl)-4-phenyl-2,3-dihydro-4h-1,4-benzoxazines useful as antipsychotics | |
CZ20012973A3 (cs) | Agonisté dopamin D1 receptoru | |
DE69418321T2 (de) | Tricyclische benzodiazepine, ihr verwendung und herstellung | |
NZ240734A (en) | 5-substituted-trans-1-piperazinoindan derivatives; their preparation and | |
DK165691B (da) | Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho(2,3-b)furan, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
JP5635905B2 (ja) | ミルタザピンの調製方法 | |
JP2002535329A (ja) | 置換1−(4−ピペリジル)−3−(アリール)イソチオウレア類、その調製およびその治療用途 | |
US20040122003A1 (en) | Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions | |
JPH04266888A (ja) | 製薬化合物 | |
MXPA02000256A (es) | Derivados fluorados novedosos de benzodioxanimidazolina, su preparacion y sus aplicaciones terapeuticas. | |
KR20010072090A (ko) | 비정형적인 향정신성 작용을 갖는피롤로[2,1-b][1,3]벤조티아제핀 | |
US5229383A (en) | Piperazine-substituted 1,4-benzoxazine derivatives and their use in treating disorders of the central nervous system | |
CZ279954B6 (cs) | Ergolinové deriváty a způsob jejich přípravy | |
WO2003053936A1 (en) | Dopamine d1 receptor agonist pro-drug compounds & derivatives | |
KR20010072407A (ko) | N-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도 | |
MXPA06010720A (en) | Process for preparing n-aryl-piperazine derivatives cross-reference to related applications |